| Literature DB >> 30686749 |
Johanna Anderson1, Kim Peterson2, Donald Bourne2, Erin Boundy2.
Abstract
Intradialytic parenteral nutrition (IDPN) is commonly requested before recommended therapies in malnourished patients on hemodialysis. This review provides updated critical synthesis of the evidence on the use of IDPN in patients on hemodialysis. We searched MEDLINE, CINAHL, and other sources to identify evidence. Two reviewers sequentially selected studies, abstracted data, rated study quality, and synthesized evidence using predefined criteria. IDPN did not improve clinically relevant outcomes compared with dietary counseling or oral supplementation and had varied results compared with usual care in 12 studies. Data are limited on adverse events or cost-effectiveness of IDPN. Important limitations of the evidence, including limited measurement of clinically important outcomes, methodological concerns, and heterogeneity between studies, weaken our confidence in these findings. IDPN may be a reasonable treatment option for patients who fail to respond or cannot receive recommended treatments, but the broad usage of IDPN before recommended treatment options does not appear warranted. Published by Elsevier Inc.Entities:
Mesh:
Year: 2019 PMID: 30686749 DOI: 10.1053/j.jrn.2018.11.009
Source DB: PubMed Journal: J Ren Nutr ISSN: 1051-2276 Impact factor: 3.655